Clinical Trial Update: A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the combination of everolimus and bevacizumab in pediatric patients with recurrent solid tumors and CNS malignancies has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Solid Tumors

Drugs mentioned

• Afinitor (everolimus)
• Avastin (bevacizumab)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Recurrent or Refractory Solid Tumors, CNS Malignancies | Phase 1 | Status: COMPLETED